Literature DB >> 2322510

Visual outcome and complications after cataract extraction in Saudi Arabia.

M F al Faran1.   

Abstract

Cataract is the leading cause of blindness in Saudi Arabia. The author studied 1383 patients who had undergone cataract extraction (total of 1520 procedures) from October 1985 to March 1986 at the King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia. All patients were observed for at least two months. Of 1520 eyes 555 (37%) achieved a visual acuity of 20/40 or better, 309 (20%) a visual acuity of 20/50-20/60 after surgery, and 656 (43%) eyes a visual acuity of 20/70 or less. The number of eyes that had intraoperative complications was 176 (12%). The number of eyes that had postoperative complications was 539 (35%). Some eyes had more than one complication. The main factors responsible for failure to achieve visual acuity of 20/40 or better were: (1) error of refraction in 492 (32%) eyes; (2) pre-existing corneal scarring and opacity in 211 (14%) eyes; (3) climatic droplet keratopathy in 134 (9%); and (4) presumed visual loss due to glaucoma in 134 (9%) eyes.

Entities:  

Mesh:

Year:  1990        PMID: 2322510      PMCID: PMC1042034          DOI: 10.1136/bjo.74.3.141

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  A review of one thousand cases of intracapsular cataract extraction: I. Complications.

Authors:  T A Meredith; A E Maumenee
Journal:  Ophthalmic Surg       Date:  1979-12

2.  Comparison between the complications of cataract surgery following local anaesthesia with short stay and general anaesthesia with a five-day hospitalisation.

Authors:  S A Vernon; H Cheng
Journal:  Br J Ophthalmol       Date:  1985-05       Impact factor: 4.638

3.  Sunlight and cataract: an epidemiologic investigation.

Authors:  R Hiller; L Giacometti; K Yuen
Journal:  Am J Epidemiol       Date:  1977-05       Impact factor: 4.897

4.  Sunlight and other risk factors for cataracts: an epidemiologic study.

Authors:  G W Collman; D L Shore; C M Shy; H Checkoway; A S Luria
Journal:  Am J Public Health       Date:  1988-11       Impact factor: 9.308

5.  The environment and the lens.

Authors:  H R Taylor
Journal:  Br J Ophthalmol       Date:  1980-05       Impact factor: 4.638

6.  Cataracts as an epidemiologic problem.

Authors:  A Sommer
Journal:  Am J Ophthalmol       Date:  1977-03       Impact factor: 5.258

7.  Blindness in Saudi Arabia.

Authors:  K F Tabbara; D Ross-Degnan
Journal:  JAMA       Date:  1986-06-27       Impact factor: 56.272

8.  Outcome of cataract surgery I. A prospective, observational study.

Authors:  P Bernth-Petersen
Journal:  Acta Ophthalmol (Copenh)       Date:  1982-04
  8 in total
  6 in total

1.  Outcomes of extracapsular surgery in eye camps of eastern Nepal.

Authors:  J K Shrestha; Y M Pradhan; T Snellingen
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

2.  Phacoemulsification at King Khaled Eye Specialist Hospital--the experience of the past.

Authors:  K D Teichmann; A A al-Rajhi; M H Jabak; S R Antonios; S Haddab; S D Smith
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

3.  The scope of the cataract problem in the Middle East and the Mediterranean.

Authors:  I A Badr
Journal:  Int Ophthalmol       Date:  1993-06       Impact factor: 2.031

4.  Evaluation of visual outcome of cataract surgery in an Indian eye camp.

Authors:  H Kapoor; A Chatterjee; R Daniel; A Foster
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

5.  Causes of blindness and the results of cataract surgical intervention in the Micronesian islands: a retrospective study.

Authors:  Narumichi Yamamoto; Yasuo Sugata; Kimio Murakami; Yukio Yamamoto
Journal:  Int Ophthalmol       Date:  2004-05       Impact factor: 2.031

6.  Prevalence and causes of visual impairment and blindness in the south western region of Saudi Arabia.

Authors:  M F al Faran; A A al-Rajhi; O M al-Omar; S A al-Ghamdi; M Jabak
Journal:  Int Ophthalmol       Date:  1993-06       Impact factor: 2.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.